ANGO - MCAP CO - AngioDynamics, Inc.

AngioDynamics, Inc. (ANGO) is implementing cutting-edge advancements in minimally invasive technologies, updating its equipment lineup through R&D centers. The company is shifting its strategic focus, replacing outdated catheters with intelligent NanoKnife systems for cancer treatment. This price chart reflects a market capitalization of 0.64. Business profitability is based on the sale of vascular therapy tools and interventional procedure instruments to global clinics.

For AngioDynamics, Inc. (ANGO), a manufacturer of vascular surgery instruments, the company's stock market valuation reflects the aggregate value of its equity. This figure is calculated by multiplying the current market price per share by the total number of outstanding securities. This metric allows investors to differentiate speculative price growth from actual business expansion. Efficient logistics and inventory optimization support profitability, justifying the asset's fundamental value. The indicator's dynamics help investors recognize an overheated asset in a timely manner.